{"blog": [], "keywords": [{"value": "Swedish Orphan Biovitrum AB (Sobi)", "name": "organizations", "rank": "1", "is_major": "Y"}, {"value": "Mergers, Acquisitions and Divestitures", "name": "subject", "rank": "2", "is_major": "N"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "3", "is_major": "N"}], "web_url": "http://www.nytimes.com/2015/04/28/business/dealbook/swedish-orphan-biovitrum-deal.html", "document_type": "article", "byline": {"person": [{"lastname": "BRAY", "firstname": "Chad", "role": "reported", "organization": "", "rank": 1}], "original": "By CHAD BRAY"}, "type_of_material": "News", "multimedia": [], "section_name": "Business Day", "word_count": "202", "source": "The New York Times", "subsection_name": "DealBook", "lead_paragraph": "Swedish Orphan Biovitrum, which makes the ReFacto AF treatment for hemophilia for Pfizer, received a preliminary offer from an undisclosed suitor.", "pub_date": "2015-04-28T00:00:00Z", "news_desk": "Business", "headline": {"print_headline": "Sobi Gets Offer", "main": "Sobi, Swedish Maker of Drugs for Rare Diseases, Receives Takeover Bid"}, "print_page": "5", "snippet": "Swedish Orphan Biovitrum, which makes the ReFacto AF treatment for hemophilia for Pfizer, received a preliminary offer from an undisclosed suitor.", "_id": "553e18d338f0d8472d91b729", "slideshow_credits": null, "abstract": "DealBook Online; Swedish Orphan Biovitrum says an unidentified suitor has sent preliminary takeover bid."}